Impact of Dose, Duration, and Immune Status on Efficacy of Ultrashort Telacebec Regimens in Mouse Models of Buruli Ulcer is a research paper published in Antimicrobial Agents and Chemotherapy (2021). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
HHS | National Institutes of Health
Grant: RO1-AI113266
Bernhard-Nocht-Institute for Tropical Medicine
Grant: Personal Grant
NIAID NIH HHS
Grant: R01 AI113266
National Institutes of Health
Grant: 5R01AI113266-04
Closing the Gaps on Buruli Ulcer Diagnosis, Treatment, and Prevention
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals